Rohgam ultra filtered plus (immune globulin 300, 25 per box).
Ended Awarded Last action
- Contract number
- N0023217F8304
- Awardee
-
Kedrion Biopharma Inc. UEI UN3DCKKLHSE7
- Awarding agency
-
Bureau of Medicine and Surgery
Department of the Navy, Department of Defense
- Obligated
- $50,318
Award facts
- Contract value 80% obligated
-
- $50,318.28 Current, with exercised options
- $62,897.85 Potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- Funding agency
- Defense Health Agency Department of Defense
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Fort Lee, NJ 07024, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $12,580 | |
| Exercise an Option | $0 | |
| Exercise an Option | $0 | |
| Exercise an Option | $12,580 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $12,580 | |
| Original award | $12,580 |
About this award
This federal contract award to Kedrion Biopharma Inc. was issued by the Defense Health Agency (DHA) as a $62,897.85 firm-fixed-price delivery order against the General Services Administration (GSA) Pharmaceuticals and Drugs schedule contract (FSS-61-IB). The contract is for the supply of RHOGAM ULTRA FILTERED PLUS (IMMUNE GLOBULIN 300, 25 PER BOX) to the DHA. There was no set-aside designation applied. Kedrion Biopharma is a manufacturer of plasma-derived pharmaceuticals used to treat rare and chronic conditions. In addition to this DHA contract, the company holds a $6 million Blanket Purchase Agreement with the Department of Veterans Affairs National Acquisition Center for the supply of Ryplazim, a therapy for plasminogen deficiency type 1, and a multiple award Federal Supply Schedule contract with the VA's Veterans Integrated Service Network 12 worth up to $24 million.
Quick answers
Who was awarded contract N0023217F8304?
N0023217F8304 was awarded to Kedrion Biopharma Inc. by Bureau of Medicine and Surgery (Department of the Navy) on October 1, 2017.
How much is contract N0023217F8304 worth?
The government has obligated $50,318 on N0023217F8304. Its potential value, with all options, is $62,898.
Which agency awarded contract N0023217F8304?
Bureau of Medicine and Surgery (Department of the Navy) awarded N0023217F8304, with funding from Defense Health Agency (Department of Defense).
Is contract N0023217F8304 an order under another contract?
Yes. N0023217F8304 is a delivery order under V797D30219, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract N0023217F8304 competed?
The extent of competition for N0023217F8304 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award